Literature DB >> 29781745

Using dextran of different molecular weights to achieve faster freeze-drying and improved storage stability of lactate dehydrogenase.

Bjarke Strøm Larsen1, Jeppe Skytte2, Anna J Svagan3, Helena Meng-Lund1, Holger Grohganz1, Korbinian Löbmann1.   

Abstract

Freeze-drying of protein formulations is frequently used to maintain protein activity during storage. The freeze-drying process usually requires long primary drying times because the highest acceptable drying temperature to obtain acceptable products is dependent on the glass transition temperature of the maximally freeze-concentrated solution (Tg'). On the other hand, retaining protein activity during storage is related to the glass transition temperature (Tg) of the final freeze-dried product. In this study, dextrans with different molecular weight (1 and 40 kDa) and mixtures thereof at the ratio 3:1, 1:1, and 1:3 (w/w) were used as cryo-/lyoprotectant and their impact on the stability of the model protein lactate dehydrogenase (LDH) was investigated at elevated temperatures (40 °C and 60 °C). The dextran formulations were then compared to formulations containing sucrose as cryo-/lyoprotectant. Because of the higher Tg' values of the dextrans, the primary drying times could be reduced compared to freeze-drying with sucrose. Similarly, the higher Tg and Tg' of dextrans relative to sucrose led to benefits during storage which was shown through improved protection of LDH activity.

Entities:  

Keywords:  Dextran; freeze-drying; lactate dehydrogenase; protein stability; storage

Mesh:

Substances:

Year:  2018        PMID: 29781745     DOI: 10.1080/10837450.2018.1479866

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  6 in total

1.  Surface Composition and Formulation Heterogeneity of Protein Solids Produced by Spray Drying.

Authors:  Nathan E Wilson; Tarun Tejasvi Mutukuri; Dmitry Y Zemlyanov; Lynne S Taylor; Elizabeth M Topp; Qi Tony Zhou
Journal:  Pharm Res       Date:  2019-12-23       Impact factor: 4.200

Review 2.  US FDA-approved therapeutic antibodies with high-concentration formulation: summaries and perspectives.

Authors:  Shawn Shouye Wang; Yifei Susie Yan; Kin Ho
Journal:  Antib Ther       Date:  2021-11-18

3.  Dextran Mass Ratio Controls Particle Drying Dynamics in a Thermally Stable Dry Powder Vaccine for Pulmonary Delivery.

Authors:  Myla Manser; Blair A Morgan; Xueya Feng; Rod G Rhem; Myrna B Dolovich; Zhou Xing; Emily D Cranston; Michael R Thompson
Journal:  Pharm Res       Date:  2022-07-19       Impact factor: 4.580

4.  Enabling Clonal Analyses of Yeast in Outer Space by Encapsulation and Desiccation in Hollow Microparticles.

Authors:  Simon Ng; Cayden Williamson; Mark van Zee; Dino Di Carlo; Sergio R Santa Maria
Journal:  Life (Basel)       Date:  2022-07-31

5.  3D Sugar Printing of Networks Mimicking the Vasculature.

Authors:  Andreas M A O Pollet; Erik F G A Homburg; Ruth Cardinaels; Jaap M J den Toonder
Journal:  Micromachines (Basel)       Date:  2019-12-30       Impact factor: 2.891

6.  Be Aggressive! Amorphous Excipients Enabling Single-Step Freeze-Drying of Monoclonal Antibody Formulations.

Authors:  Christina Haeuser; Pierre Goldbach; Joerg Huwyler; Wolfgang Friess; Andrea Allmendinger
Journal:  Pharmaceutics       Date:  2019-11-17       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.